New screening technology available at the European Lead Factory

03 September 2019

Pivot Park Screening Centre (PPSC) is excited to announce the availability of a novel technology for screening in European Lead Factory.

Adding to our already broad portfolio of read-out technologies, we now installed a Bruker Rapiflex for high throughput mass-spectrometry screening. The MALDI PharmaPulse label-free technology will improve speed and quality of our European Lead Factory programs by reducing the number of false positives or false negatives. This technology is particularly suitable for biochemical programs. Program owners that already have developed a mass-spec assay are now welcome to submit their program to the European Lead Factory.

Photo by Pivot Park Screening Centre: The first mass spectrometry experiments on the Rapiflex are performed at PPSC.